| dc.contributor.author |
Paul, Atish Tulshiram |
|
| dc.date.accessioned |
2024-01-02T04:51:34Z |
|
| dc.date.available |
2024-01-02T04:51:34Z |
|
| dc.date.issued |
2022-11 |
|
| dc.identifier.uri |
https://www.ingentaconnect.com/content/ben/lddd/2022/00000019/00000011/art00003 |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13590 |
|
| dc.description.abstract |
Obesity is a multifactorial metabolic disease characterised by excessive accumulation of triglycerides. The prevalence and morbidity rates associated with obesity are increasing tremendously, posing a significant risk to society. Pancreatic lipase (PL) is a key enzyme responsible for the digestion of dietary triglycerides; hence its inhibition is considered an attractive target in obesity. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Bentham Science |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
Obesity |
en_US |
| dc.subject |
Enzyme inhibition |
en_US |
| dc.subject |
Fluorescence spectroscopy |
en_US |
| dc.subject |
Molecular docking |
en_US |
| dc.subject |
Pancreatic lipase |
en_US |
| dc.subject |
Thiazolidinediones (TZDs) |
en_US |
| dc.title |
Design and Synthesis of Echitamine-inspired Hybrid Analogues Containing Thiazolidinediones as Potential Pancreatic Lipase Inhibitors |
en_US |
| dc.type |
Article |
en_US |